Breast fat grafting, also called autologous fat transfer or lipofilling, uses tissue collected from another area of the patient’s own body to adjust breast volume, contour, or asymmetry. Suitability depends on anatomy, available donor fat, expectations, medical history, and individualized clinical and imaging assessment.
Appropriate timing
The procedure combines liposuction from one or more donor areas with preparation and transfer of small amounts of fat to selected breast regions. It may be considered for contour differences, refinement after other procedures, or a modest increase in volume. The amount that remains varies, and some of the transferred tissue may be reabsorbed over time. The outcome therefore should not be presented as fully predictable or as equivalent to an implant.
Fat grafting alone does not correct every degree of skin laxity, breast droop, or tissue change. When these factors are present, the consultation should address other surgical options and whether techniques may or may not be combined, according to the individual assessment.
Assessment before surgery
Assessment includes medical and surgical history, medications, weight changes, personal and family breast history, physical examination, and review of potential donor areas. Breast imaging may be requested or updated according to age, symptoms, individual risk, and the recommendations of the clinician responsible for breast health.
Available fat, tissue quality, the desired volume, and the ability to attend follow-up appointments all influence the decision. A new lump, discharge, persistent pain, recent change, or inconclusive imaging finding should be investigated before elective surgery.
Key considerations
Planning addresses the donor areas, access points, placement plane, proposed volume, anesthesia, and the setting in which the procedure will take place. The method of harvesting, preparing, and injecting fat should be selected by the surgeon according to the case and available resources.
Liposuction or assessment equipment may be considered as one part of an individualized plan. Available resources include technologies described by InMode/IGNITE, Solta/VASER, and DEKA. The presence of a technology does not determine indication, fat retention, outcome, or freedom from complications; these depend on assessment, technique, and follow-up.
Imaging, follow-up, and breast health
After fat grafting, benign changes such as fat necrosis, oil cysts, palpable nodules, scars, or calcifications may occur. These findings can appear on mammography, ultrasound, or MRI and may sometimes require additional imaging or biopsy for clarification. [1] [2]
The procedure should be reported to the imaging center and to the clinicians involved in breast care. The timing and type of mammography, ultrasound, MRI, or other examination is not the same for everyone; it should take into account prior imaging, individual risk, symptoms, and local protocols.
Available studies, particularly in breast reconstruction, have not shown a clear clinical association between fat grafting and increased recurrence, but the evidence has limitations and does not establish individual oncologic safety. [1] [2] Patients with a previous breast cancer diagnosis, hereditary predisposition, or an ongoing investigation should have the decision coordinated, when appropriate, with a breast surgeon, oncologist, radiologist, and plastic surgeon.
Risks, limitations, and recovery
In addition to risks related to anesthesia and liposuction, possible events include infection, bleeding, asymmetry, contour irregularities, pain, sensory changes, seroma, hematoma, partial loss of transferred fat, fat necrosis, cysts, calcifications, and the need for further treatment. Serious complications are uncommon but can occur and should be discussed before consent. [3]
Recovery varies with the extent of surgery and the areas treated. Follow-up assesses wounds, swelling, signs of infection, donor-site healing, and changes in breast volume. Fever, progressive redness, drainage, severe pain, shortness of breath, or sudden swelling requires prompt medical contact or urgent assessment.
Shared decision-making
The decision should follow a realistic discussion of goals, alternatives, limits of available tissue, possible partial reabsorption, and the need for imaging follow-up. Clinical photographs, when included in the medical record, are for documentation and are not a promise of outcome; public-facing images do not replace an individual assessment.
Frequently asked questions
Does fat grafting enlarge the breasts like an implant?
No. Fat grafting uses autologous fat and may produce a variable increase, influenced by available tissue and graft retention. It is not equivalent to an implant and should not be presented as a universal substitute.
Does all transferred fat remain?
Not necessarily. Some of the fat may be reabsorbed, and volume can change during recovery or with weight fluctuations. Individual behavior cannot be predicted before surgery.
Can the procedure affect mammography?
It can cause findings such as oil cysts, fat necrosis, or calcifications. Many findings can be characterized as benign, but some require additional evaluation. The procedure should always be disclosed to the imaging service and recommended screening should continue.
Can someone with a history of breast cancer undergo fat grafting?
Possibility depends on the cancer history, prior treatment, current findings, and coordinated assessment by the relevant clinicians. Individual oncologic safety should not be asserted without that review.
Can nanofat be used in the breasts?
Nanofat refers to a specifically processed fat preparation. Any possible use should be discussed individually, including its indication, available evidence, limitations, and risks; it does not predict an outcome or additional safety.
References
Medical review note
Educational content prepared with clinically cautious language. It should be checked and updated by the responsible plastic surgeon and, when applicable, by clinicians involved in breast care. It does not replace consultation, physical examination, imaging, or individualized decision-making.